Clinical Trail to Evaluate the Efficacy and Safety of DWJ1451
Condition: Hypertension, Dyslipidemia Interventions: Drug: Amlodipine/Olmesartan 10/40mg (Combination drug), Ezetimibe/Rosuvastatin 10/20mg(Combination drug); Drug: Olmesartan 40mg, Ezetimibe/Rosuvastatin 10/20mg(Combination drug); Drug: Amlodipine/Olmesartan 10/40mg (Combination drug) Sponsor: Daewoong Pharmaceutical Co. LTD. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials